BR112014010560A2 - drogas para inibir p38 e usos das mesmas - Google Patents
drogas para inibir p38 e usos das mesmasInfo
- Publication number
- BR112014010560A2 BR112014010560A2 BR112014010560A BR112014010560A BR112014010560A2 BR 112014010560 A2 BR112014010560 A2 BR 112014010560A2 BR 112014010560 A BR112014010560 A BR 112014010560A BR 112014010560 A BR112014010560 A BR 112014010560A BR 112014010560 A2 BR112014010560 A2 BR 112014010560A2
- Authority
- BR
- Brazil
- Prior art keywords
- inhibiting drugs
- drugs
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201131754A ES2396764B1 (es) | 2011-11-02 | 2011-11-02 | FÁRMACOS INHIBIDORES DE p38 Y APLICACIONES. |
| PCT/ES2012/070762 WO2013064714A1 (es) | 2011-11-02 | 2012-10-31 | Fármacos inhibidores de p38 y aplicaciones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014010560A2 true BR112014010560A2 (pt) | 2017-04-25 |
Family
ID=48191418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014010560A BR112014010560A2 (pt) | 2011-11-02 | 2012-10-31 | drogas para inibir p38 e usos das mesmas |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9096554B2 (pt) |
| EP (1) | EP2774613A4 (pt) |
| JP (1) | JP2014532688A (pt) |
| KR (1) | KR20140085580A (pt) |
| AU (1) | AU2012331016A1 (pt) |
| BR (1) | BR112014010560A2 (pt) |
| CA (1) | CA2854349A1 (pt) |
| ES (1) | ES2396764B1 (pt) |
| WO (1) | WO2013064714A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2396764B1 (es) | 2011-11-02 | 2013-12-19 | Universidad Autónoma de Madrid | FÁRMACOS INHIBIDORES DE p38 Y APLICACIONES. |
| US9757379B2 (en) | 2012-11-14 | 2017-09-12 | The Board Of Regents Of The University Of Texas System | Inhibition of HIF-2α heterodimerization with HIF1β (ARNT) |
| JP6473146B2 (ja) * | 2013-10-11 | 2019-02-20 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ピロロトリアジンキナーゼ阻害剤 |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID30439A (id) | 1999-01-13 | 2001-12-06 | Warner Lambert Co | Benzoheterosiklus dan penggunaannya sebagai penghambat mek |
| KR20020015376A (ko) | 1999-07-16 | 2002-02-27 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | Ｍｅｋ 억제제를 사용한 만성 통증의 치료 방법 |
| WO2004004725A2 (en) | 2002-07-09 | 2004-01-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| US20040110755A1 (en) | 2002-08-13 | 2004-06-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Combination therapy with p38 MAP kinase inhibitors and their pharmaceutical compositions |
| AU2003268424A1 (en) | 2002-09-05 | 2004-03-29 | Scios Inc. | Treatment of pain by inhibition of p38 map kinase |
| US20080039461A1 (en) | 2002-09-05 | 2008-02-14 | Protter Andrew A | Treatment of pain by inhibition of p38 map kinase |
| WO2005032551A1 (en) | 2003-09-30 | 2005-04-14 | Scios Inc. | TREATMENT OF CARDIOVASCULAR DISEASE WITH INHIBITORS OF p38 KINASE |
| JP2008503591A (ja) * | 2004-06-22 | 2008-02-07 | ライジェル ファーマシューティカルズ， インコーポレイテッド | ユビキチンリガーゼ阻害剤 |
| WO2006127678A2 (en) | 2005-05-23 | 2006-11-30 | Smithkline Beecham Corporation | Inhibition of p38 mark for treatment of obesity |
| WO2008124838A1 (en) | 2007-04-10 | 2008-10-16 | University Of Maryland, Baltimore | Compounds that inhibit human dna ligases and methods of treating cancer |
| GB0713311D0 (en) | 2007-07-10 | 2007-08-22 | Nene Group Plc | Pallet racking shield |
| DE102007060008A1 (de) | 2007-12-13 | 2009-06-18 | Technolas Gmbh Ophthalmologische Systeme | Bestimmung und Überwachumg von Laserenergie |
| WO2010083404A2 (en) | 2009-01-16 | 2010-07-22 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Linked myc-max small molecule inhibitors |
| US20120122896A1 (en) * | 2009-05-08 | 2012-05-17 | Pike Pharma Gmbh | 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication |
| ES2396764B1 (es) | 2011-11-02 | 2013-12-19 | Universidad Autónoma de Madrid | FÁRMACOS INHIBIDORES DE p38 Y APLICACIONES. |
-
2011
- 2011-11-02 ES ES201131754A patent/ES2396764B1/es active Active
-
2012
- 2012-10-31 US US14/355,545 patent/US9096554B2/en not_active Expired - Fee Related
- 2012-10-31 EP EP12846045.8A patent/EP2774613A4/en not_active Withdrawn
- 2012-10-31 JP JP2014539368A patent/JP2014532688A/ja active Pending
- 2012-10-31 AU AU2012331016A patent/AU2012331016A1/en not_active Abandoned
- 2012-10-31 KR KR1020147014457A patent/KR20140085580A/ko not_active Application Discontinuation
- 2012-10-31 CA CA2854349A patent/CA2854349A1/en not_active Abandoned
- 2012-10-31 WO PCT/ES2012/070762 patent/WO2013064714A1/es active Application Filing
- 2012-10-31 BR BR112014010560A patent/BR112014010560A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140085580A (ko) | 2014-07-07 |
| US9096554B2 (en) | 2015-08-04 |
| JP2014532688A (ja) | 2014-12-08 |
| WO2013064714A8 (es) | 2014-06-12 |
| WO2013064714A1 (es) | 2013-05-10 |
| ES2396764B1 (es) | 2013-12-19 |
| ES2396764A1 (es) | 2013-06-19 |
| CA2854349A1 (en) | 2013-05-10 |
| AU2012331016A1 (en) | 2014-06-26 |
| EP2774613A1 (en) | 2014-09-10 |
| US20140296308A1 (en) | 2014-10-02 |
| EP2774613A4 (en) | 2015-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3608325T3 (da) | Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse | |
| CO7030961A2 (es) | Benzotienilo-pirrolotriazinas disustituidas y sus usos | |
| BR112013012969A2 (pt) | índices de fatiga e usos para os mesmos | |
| BR112013023156A2 (pt) | artigos para cuidados pessoais | |
| DK3202760T3 (da) | Pegylerede lipider og deres anvendelse til lægemiddelfremføring | |
| DK3597644T3 (da) | Kationiske aminlipider og anvendelser deraf | |
| BR112015014063A2 (pt) | anticorpos anti-b7-h4 humano e seus usos. | |
| BR112013033444A2 (pt) | formulações para terapia de ferida | |
| BR112013033098A2 (pt) | inibidores de glicosidade seletivos e usos dos mesmos | |
| BR302012002887S1 (pt) | Configuração aplicada em garrafa para cuidado pessoal | |
| DOS2012000102S (es) | Alimento para animales | |
| BR112015004817A2 (pt) | bioconjugados compreendendo antígenos modificados e seus usos | |
| DOS2012000101S (es) | Alimento para animales | |
| BR112015003789A2 (pt) | estrutura de encaixe remodelável e produto médico | |
| BR112014009770A2 (pt) | composição espumada para cuidados pessoais | |
| BR112014013682A2 (pt) | composição para cuidado pessoal | |
| BR112014005254A2 (pt) | composições antimicrobianas e usos das mesmas | |
| BR112015007217A2 (pt) | compostos e usos do composto | |
| BR112013033919A2 (pt) | combinações e seus usos | |
| DOS2012000103S (es) | Alimento para animales | |
| BR302013000341S1 (pt) | Configuração aplicada em aplicador para cosméticos | |
| DK2943460T3 (da) | 6-chlor-3-(phenyl-d5)-inden-1-on og anvendelse deraf | |
| BR112014010560A2 (pt) | drogas para inibir p38 e usos das mesmas | |
| BR112014016615A8 (pt) | nucleosídios carbocíclicos, seus usos farmacêuticos e composições | |
| BR112014013684A2 (pt) | composição para cuidado pessoal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |